News
New research from Northwestern University in Illinois found that Duavee, a Pfizer-made drug, “significantly reduced” breast tissue cell growth, which is a major indicator of cancer ...
Psychedelics research gains support from the Trump administration for treating PTSD and mental health conditions, with Veterans Affairs exploring treatments that show promise in clinical trials.
1d
The Business & Financial Times on MSNBuilding the One Square Mile: Phasing and Civil Works Execution Plan (3)By Sammy CRABBEInfrastructure alone does not make a city great. Roads, grids, and buildings create the skeleton, but it is innovation, creativity, and collaboration that breathe life into the body. As ...
New research presented at the 2025 American Society for Clinical Oncology’s (ASCO) annual meeting has shed light on the ...
Under the new law, anyone in Montana can legally access drugs that have passed just one phase 1 clinical trial.
The trial is evaluating EB103, which is a CD19-redirected ARTEMIS® T-cell therapy, in adult patients (aged 18 and older) with ...
The analysts are supporting the company’s potential in the broader mental health sector, demonstrating the transformative ...
Highlights from the 2025 Global Equine Endocrinology Symposium included never-before-presented study results on insulin ...
Several oral abstracts presented at the American Society of Clinical Oncology’s annual meeting highlight ongoing research of Keytruda, Opdivo, Tecentriq and more in skin cancer.
Reducing the length of immunotherapy treatment for an advanced skin cancer did not significantly diminish disease control ...
IVMED-85 is a preservative-free, non-atropine daily drop that slows myopia progression by strengthening scleral and corneal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results